1.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: under 21 Sponsor: NCI Protocol IDs: POG-8155
|
|
2.
|
Phase: Phase II Type: Treatment Status: Closed Age: over 16 Sponsor: NCI Protocol IDs: SWOG-8051
|
|
3.
|
Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: MAYO-805002, NCCTG-805002, NCI-W81-0587
|
|
4.
|
Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: MAYO-814603
|
|
5.
|
Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: MAYO-816101
|
|
6.
|
Phase: Phase II Type: Treatment Status: Completed Age: no age specified Sponsor: NCI Protocol IDs: EST-1882
|
|
7.
|
Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: SWOG-8304
|
|
8.
|
Phase: Phase II Type: Treatment Status: Completed Age: no age specified Sponsor: NCI Protocol IDs: NCCTG-837051, NCCTG-83-70-51
|
|
9.
|
Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: MAYO-804601
|
|
10.
|
Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: MAYO-807003
|
|
11.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over (13 and over for osteosarcoma only) Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: MSKCC-03029, SALMEDIX-SDX-102-01, NCT00062283
|
|
12.
|
Phase: Phase I Type: Treatment Status: Closed Age: 15 and over Sponsor: Protocol IDs: MAYO-810103, NCI-W82-0760, W82-0760
|
|
13.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NABTT-0303, NCT00075894
|